MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives

Multiple myeloma (MM) is the second most common hematological malignancy. Despite the huge therapeutic progress thanks to the introduction of novel therapies, MM remains an incurable disease. Extensive research is currently ongoing to find new options. MicroRNAs (miRNAs) are small, non-coding RNA mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Szudy-Szczyrek, Aneta, Ahern, Sean, Krawczyk, Janusz, Szczyrek, Michał, Hus, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503263/
https://www.ncbi.nlm.nih.gov/pubmed/36143213
http://dx.doi.org/10.3390/jpm12091428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503263/
https://www.ncbi.nlm.nih.gov/pubmed/36143213
http://dx.doi.org/10.3390/jpm12091428

Ejemplares similares